Table 3.

Biochemical parameters of the subjects at baseline, day 45 and day 90 of the study

Parameter	Baseline	Day 45	Day 90	F value	P value
Total Cholesterol (mg/dl)
Experimental	207.1 ± 32.5	208.2 ± 32.3	198.5 ± 33.2	2.53	0.09
Placebo	204.9 ± 23.9	202.6 ± 24.3	198.6 ± 21.2
HDL Cholesterol (mg/dl)
Experimental	42.0 ± 9.4	41.6 ± 9.5	42.6 ± 8.9	0.32	0.73
Placebo	40.9 ± 9.2	39.6 ± 9.0	41.2 ± 9.3
LDL cholesterol (mg/dl)
Experimental	155.3 ± 13.9	145.2 ± 25.6	127.6 ± 24.1*	1.0	0.36
Placebo	150.7 ± 14.3	142.4 ± 24.8	132.0 ± 17.1*
Serum Triglycerides (mg/dl)
Experimental	159.9 ± 90.6	134.6 ± 56.2	143.3 ± 73.9*	0.07	0.92
Placebo	144.6 ± 60.1	134.6 ± 56.2	130.6 ± 51.2
Fasting Blood Glucose (mg/dl)
Experimental	93.7 ± 9.3	89.7 ± 13.7	93.1 ± 9.9	2.5	0.09
Placebo	88.8 ± 9.6	91.4 ± 13.7	92.2 ± 8.5
Post Prandial Blood Glucose (mg/dl)
Experimental	100.9 ± 26.3	110.7 ± 29.6	110.6 ± 21.6	1.2	0.32
Placebo	97.2 ± 20.9	104.4 ± 17.7	113.4 ± 18.7

Mean ± SD. n = 28 in experimental group and 29 in Placebo group. No significant interaction between time points and group (repeated measure ANOVA with group as between subject factor). *-Significant difference observed between time points within each group (repeated measure ANOVA).